Heterozygous rare variants in TREM2 increase the risk for neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis [31–34]. This evidence concerns the gene TREM2 and neurodegenerative disease.